BioStock: Saniona-backed Cephagenix secures 9 MEUR in seed financing
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Sparkonto: Upp till 3,20 % ränta – 7 sparkonton som fortfarande ger hög ränta i februari

Pressmeddelande

BioStock: Saniona-backed Cephagenix secures 9 MEUR in seed financing

Cision Publicerad: 16 Jan 11:23
Saniona

Saniona has announced that Cephagenix, a joint venture with Professor Jes Olesen at the University of Copenhagen, has successfully raised up to 9 MEUR  in tranched seed financing. The funding round was led by AdBio Partners and AbbVie Ventures and aims to accelerate the development of Cephagenix’s vascular KATP channel inhibitor program, targeting novel anti-migraine therapies. BioStock reached out to Saniona's CEO Thomas Feldthus for a comment.

Read the interview with Thomas Feldthus at biostock.se:

https://www.biostock.se/en/2025/01/saniona-backed-cephagenix-secures-9-meur-in-seed-financing/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Nyheter om Saniona

Läses av andra just nu

Om aktien Saniona

Senaste nytt